TAR DNA-binding protein 43 in neurodegenerative disease
暂无分享,去创建一个
John Q. Trojanowski | J. Trojanowski | V. Lee | A. Chen-Plotkin | Alice S. Chen-Plotkin | Virginia M.-Y. Lee
[1] J. Taylor,et al. Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy , 2007, Acta Neuropathologica.
[2] S. Greenberg,et al. Nuclear localization of valosin‐containing protein in normal muscle and muscle affected by inclusion‐body myositis , 2007, Muscle & nerve.
[3] E. Buratti,et al. Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene , 2005, Nucleic acids research.
[4] Hurng‐Yi Wang,et al. Structural diversity and functional implications of the eukaryotic TDP gene family. , 2004, Genomics.
[5] S. Reske,et al. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD , 2005, Annals of neurology.
[6] A. Hillis,et al. Frontotemporal degeneration, Pick's disease, Pick complex, and Ravel , 2003, Annals of neurology.
[7] B. Dubois,et al. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration , 2009, Annals of neurology.
[8] J. Growdon,et al. Cerebrospinal fluid levels of amyloid β‐protein in alzheimer's disease: Inverse correlation with severity of dementia and effect of apolipoprotein e genotype , 1995, Annals of neurology.
[9] H. Akiyama,et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.
[10] A. Brun. Identification and Characterization of Frontal Lobe Degeneration: Historical Perspective on the Development of FTD , 2007, Alzheimer disease and associated disorders.
[11] M. Strong,et al. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein , 2007, Molecular and Cellular Neuroscience.
[12] J. Rothstein. TDP‐43 in amyotrophic lateral sclerosis: Pathophysiology or patho‐babel? , 2007, Annals of neurology.
[13] Andrea D'Ambrogio,et al. Structural determinants of the cellular localization and shuttling of TDP-43 , 2008, Journal of Cell Science.
[14] Murray Grossman,et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis , 2008, The Lancet Neurology.
[15] N. Bresolin,et al. TARDBP (TDP‐43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations , 2009, European journal of neurology.
[16] M. Freedman,et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[17] J. Trojanowski,et al. Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations. , 2008, Archives of neurology.
[18] J. Trojanowski,et al. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2008, Archives of neurology.
[19] J. Trojanowski,et al. Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease , 2007, Acta Neuropathologica.
[20] R. Petersen,et al. Neuropathologic Features of Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions With Progranulin Gene (PGRN) Mutations , 2007, Journal of neuropathology and experimental neurology.
[21] Chi Li,et al. Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] C. Burd,et al. hnRNP proteins and the biogenesis of mRNA. , 1993, Annual review of biochemistry.
[23] I. Mackenzie,et al. The molecular basis of frontotemporal dementia , 2009, Expert Reviews in Molecular Medicine.
[24] F. Baralle,et al. TDP43 depletion rescues aberrant CFTR exon 9 skipping , 2006, FEBS letters.
[25] D. Mann,et al. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis , 2008, Acta Neuropathologica.
[26] E. Buratti,et al. Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance. , 2004, American journal of human genetics.
[27] Bin Zhang,et al. Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform , 1999, Neuron.
[28] Xun Hu,et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.
[29] J. Trojanowski,et al. Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations , 2007, Annals of neurology.
[30] John L. Robinson,et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. , 2009, Archives of neurology.
[31] J. Trojanowski,et al. TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease , 2007, Acta Neuropathologica.
[32] Ralf Janknecht,et al. EWS-ETS oncoproteins: the linchpins of Ewing tumors. , 2005, Gene.
[33] M. Morita,et al. Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis , 2008, Annals of neurology.
[34] H. Akiyama,et al. Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies , 2009, Acta Neuropathologica.
[35] T. Dörk,et al. Nuclear factor TDP‐43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping , 2001, The EMBO journal.
[36] J. Trojanowski,et al. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.
[37] J L Haines,et al. Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .
[38] K. Talbot,et al. TARDBP in amyotrophic lateral sclerosis: identification of a novel variant but absence of copy number variation , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[39] H. Arai,et al. Concurrence of TDP-43, tau and α-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies , 2007, Brain Research.
[40] D. Dickson,et al. TDP-43 in differential diagnosis of motor neuron disorders , 2007, Acta Neuropathologica.
[41] B. Ghetti,et al. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea , 2009, Movement disorders : official journal of the Movement Disorder Society.
[42] J. Yong,et al. The SMN complex: an assembly machine for RNPs. , 2006, Cold Spring Harbor symposia on quantitative biology.
[43] J. Trojanowski,et al. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2008, The American journal of pathology.
[44] V. Meininger,et al. Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis , 2008, Journal of Medical Genetics.
[45] L. Chang,et al. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease , 1995, Neurology.
[46] P. Reddi,et al. A Novel CpG-free Vertebrate Insulator Silences the Testis-specific SP-10 Gene in Somatic Tissues , 2007, Journal of Biological Chemistry.
[47] J. Weissenbach,et al. Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.
[48] H. Shill,et al. No evidence for cognitive dysfunction or depression in patients with mild restless legs syndrome , 2009, Movement disorders : official journal of the Movement Disorder Society.
[49] A. Pestronk,et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[50] J. Trojanowski,et al. Concomitant TAR-DNA-Binding Protein 43 Pathology Is Present in Alzheimer Disease and Corticobasal Degeneration but Not in Other Tauopathies , 2008, Journal of neuropathology and experimental neurology.
[51] J. Trojanowski,et al. TDP-43: a novel neurodegenerative proteinopathy , 2007, Current Opinion in Neurobiology.
[52] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[53] J. Trojanowski,et al. Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein-43 pathology. , 2009, Archives of neurology.
[54] M. Stoler,et al. cis-requirement for the maintenance of round spermatid-specific transcription. , 2006, Developmental biology.
[55] B. Castellotti,et al. High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis , 2009, Human mutation.
[56] P. Mcgeer,et al. Colocalization of Transactivation-Responsive DNA-Binding Protein 43 and Huntingtin in Inclusions of Huntington Disease , 2008, Journal of neuropathology and experimental neurology.
[57] M. Farrer,et al. Pallidonigral TDP-43 pathology in Perry syndrome. , 2009, Parkinsonism & related disorders.
[58] H. Kretzschmar,et al. A new subtype of frontotemporal lobar degeneration with FUS pathology. , 2009, Brain : a journal of neurology.
[59] Yaowu He,et al. Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B , 2008, Cellular and Molecular Life Sciences.
[60] A. D’Ambrogio,et al. Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo , 2009, Nucleic acids research.
[61] G. Schellenberg,et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.
[62] S. Melquist,et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.
[63] L. Petrucelli,et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity , 2009, Proceedings of the National Academy of Sciences.
[64] H. Akiyama,et al. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43 , 2009, Alzheimer's & Dementia.
[65] D. Cleveland,et al. Rethinking ALS: The FUS about TDP-43 , 2009, Cell.
[66] J. Trojanowski,et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. , 2008, Archives of neurology.
[67] N. Cairns,et al. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration , 2009, Proceedings of the National Academy of Sciences.
[68] D. Neary,et al. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43 , 2007, Acta Neuropathologica.
[69] E. Buratti,et al. TDP-43 Binds Heterogeneous Nuclear Ribonucleoprotein A/B through Its C-terminal Tail , 2005, Journal of Biological Chemistry.
[70] A. Kakita,et al. TDP‐43 mutation in familial amyotrophic lateral sclerosis , 2008, Annals of neurology.
[71] John L. Robinson,et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases , 2007, Acta Neuropathologica.
[72] D. Geschwind,et al. Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis , 2008, PLoS genetics.
[73] J. Trojanowski,et al. Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies* , 2009, Journal of Biological Chemistry.
[74] B. McConkey,et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis , 2008, Nature Genetics.
[75] O. Yokota,et al. Pick's disease. , 2012, Advances in experimental medicine and biology.
[76] G. Comi,et al. Mutations of FUS gene in sporadic amyotrophic lateral sclerosis , 2009, Journal of Medical Genetics.
[77] H. Feldman,et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. , 2006, Brain : a journal of neurology.
[78] T. Miki,et al. Screening for TARDBP mutations in Japanese familial amyotrophic lateral sclerosis , 2009, Journal of the Neurological Sciences.
[79] Shin J. Oh,et al. Mutant dynactin in motor neuron disease , 2003, Nature Genetics.
[80] N. M. Reddy,et al. Higher order arrangement of the eukaryotic nuclear bodies , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[81] B Miller,et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. , 2001, Archives of neurology.
[82] J. Trojanowski,et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies , 2009, Acta Neuropathologica.
[83] John Q Trojanowski,et al. Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. , 2009, Human molecular genetics.
[84] D. Dickson,et al. TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease , 2007, Annals of neurology.
[85] D. Neary,et al. TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration , 2008, Acta Neuropathologica.
[86] William T. Hu,et al. Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease , 2008, Acta Neuropathologica.
[87] B. Miller,et al. Are amyotrophic lateral sclerosis patients cognitively normal? , 2003, Neurology.
[88] A. Pick,et al. Uber die Beziehungen der senilen Hirnatrophie zur Aphasie , 1892 .
[89] Xun Hu,et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.
[90] J. Trojanowski,et al. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. , 1991, Science.
[91] A. Alzheimer. über eigenartige Krankheitsfälle des späteren Alters , 1911 .
[92] John Q. Trojanowski,et al. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases , 2009, Journal of Neurology.
[93] C. Duijn,et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.
[94] V. Meininger,et al. Mutations in FUS cause FALS and SALS in French and French Canadian populations , 2009, Neurology.
[95] J. Trojanowski,et al. Disturbance of Nuclear and Cytoplasmic TAR DNA-binding Protein (TDP-43) Induces Disease-like Redistribution, Sequestration, and Aggregate Formation* , 2008, Journal of Biological Chemistry.
[96] E. Buratti,et al. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. , 2008, Frontiers in bioscience : a journal and virtual library.
[97] D Harrich,et al. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs , 1995, Journal of virology.
[98] R. Faber,et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.
[99] J. Trojanowski,et al. Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration. , 2008, Human molecular genetics.
[100] J. Morris,et al. TDP‐43 A315T mutation in familial motor neuron disease , 2008, Annals of neurology.
[101] S. Lindquist,et al. A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity , 2008, Proceedings of the National Academy of Sciences.
[102] T. Beach,et al. Abnormal phosphorylation of Ser409/410 of TDP‐43 in FTLD‐U and ALS , 2008, FEBS letters.
[103] H. Akiyama,et al. TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. , 2007, Brain : a journal of neurology.
[104] J. Morris,et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. , 2007, The American journal of pathology.
[105] K. Talbot,et al. Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease. , 2006, Human molecular genetics.
[106] Tom Misteli,et al. TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression , 2008, Proceedings of the National Academy of Sciences.
[107] J. Trojanowski,et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations , 2008, Acta Neuropathologica.
[108] S. Pantano,et al. Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function. , 2005, Journal of molecular biology.
[109] M. Swash,et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[110] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[111] J. Trojanowski,et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. , 2006, The American journal of pathology.
[112] A. Pestronk,et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.
[113] J. Trojanowski,et al. Pathological TDP-43 in parkinsonism–dementia complex and amyotrophic lateral sclerosis of Guam , 2007, Acta Neuropathologica.
[114] John Q Trojanowski,et al. Progress from Alzheimer's tangles to pathological tau points towards more effective therapies now. , 2006, Journal of Alzheimer's disease : JAD.
[115] Jennifer Farmer,et al. Frontotemporal dementia: Clinicopathological correlations , 2006, Annals of neurology.
[116] Roland G Henry,et al. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. , 2007, Archives of neurology.
[117] M. Farrer,et al. DCTN1 mutations in Perry syndrome , 2009, Nature Genetics.
[118] J. Hodges,et al. Clinicopathological correlates in frontotemporal dementia , 2004, Annals of neurology.